Ayurvedic Management of Coronary Artery Disease - A Review
AbstractAyurvedic scholars has describe the Hridya as one of theâ€™ Dashapranayatanâ€™(1). They also describe Hridya as a â€˜mahatâ€™ means important organ of the body and `arthaâ€™ means working 24Ã—7 from birth to till death(gatiman)(2). Sushrut samhita mentioned the Hridya as a place of `cetanaâ€™(3). Ayurvedic scholars give very much importance to Hridya. Apart from this ayurvedic scholars has mentioned Hridyarogas (cardiovascular disease) in much details and mentioned their treatment part also(4). Coronary Artery Disease(CAD) is one of the cardiovascular diseases. CAD affects Indians with greater frequency and at a younger age than counterparts in developed countries as well as many other developing countries. Age standardized CAD death rates in people 30-69 years old are 405 per 100000 in India . Also 50 percent of CAD related deaths in India occur in people below 70 years of age. India is estimated to have lost 8.7 billion 1998 international dollars in 2005 because of CAD, stroke and diabetes. These estimates increase to 54 billion 1998 international dollars by 2015. Hence we have to give attention towards CAD.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.